Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_assertion type Assertion NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_head.
- NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_assertion description "[We compared the frequency of FLT3-length mutations (FLT3-LM), FLT3-TKD, MLL-partial tandem duplications (MLL-PTD), NRAS, and KITD816 in 381 patients with MDS refractory anemia with excess blasts [RAEB] n=49; with ringed sideroblasts [RARS] n=310; chronic monomyelocytic leukemia [CMML] n=22) and in 4130 patients with AML (de novo: n=3139; secondary AML [s-AML] following MDS: n=397; therapy-related [t-AML]: n=233; relapsed: n=361).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_provenance.
- NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_assertion evidence source_evidence_literature NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_provenance.
- NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_assertion SIO_000772 17550846 NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_provenance.
- NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_assertion wasDerivedFrom befree-20150227 NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_provenance.
- NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_assertion wasGeneratedBy ECO_0000203 NP666077.RAfuRBUwUWYwDddiRb1srC0KXQVO8ikg1XTC8kSwqVejE130_provenance.